The 2-Minute Rule for Atabecestat
Other clinical trials in individuals with non-Hodgkin's lymphoma [24] and individuals with Innovative malignancy [14] have demonstrated also that zosuquidar did not substantially influence the pharmacokinetics of doxorubicin and had moderate consequences over the pharmacokinetics of vincristine. These scientific trials approved that zosuquidar coul